Facile Approach to Construct Ternary Cocktail Nanoparticles for Cancer Combination Therapy

Bioconjugate Chemistry

Volumn 27, Issue 7, 2016, Pages 1564-1568

  Huang, Ping ^a   Ao, Junping ^b   Zhou, Linzhu ^a   Su, Yue ^a   Huang, Wei ^a   Zhu, Xinyuan ^a   Yan, Deyue ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG DELIVERY; DISEASES; DRUG PRODUCTS; TARGETED DRUG DELIVERY;

AMPHIPHILIC DRUGS; ANTICANCER DRUG; BIODISTRIBUTIONS; COMBINATION THERAPY; DRUG COMBINATIONS; DRUG-CONJUGATES; GEMCITABINE; MOLAR RATIO; THERAPEUTIC AGENTS; TUNABLES;

NANOPARTICLES;

CHLORAMBUCIL; GEMCITABINE; IRINOTECAN; NANOPARTICLE; TERNARY COCKTAIL NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG CARRIER;

A549 CELL LINE; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CARBON NUCLEAR MAGNETIC RESONANCE; CARCINOMA CELL LINE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG POTENTIATION; DRUG RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROPHOBICITY; IC50; LIQUID CHROMATOGRAPHY; LUNG CARCINOMA; MASS SPECTROMETRY; PHOTON CORRELATION SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; A-549 CELL LINE; CHEMICAL PHENOMENA; CHEMISTRY;

A549 CELLS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG CARRIERS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NANOPARTICLES;

EID: 84979530449     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.6b00158     Document Type: Article

References (41)

1. Ho, D. D. (1995) Time of hit HIV, early and hard N. Engl. J. Med. 333, 450-451 10.1056/NEJM199508173330710
2. Bahadur, K. C. R. and Xu, P. (2012) Multicompartment intracellular self-expanding nanogel for targeted delivery of drug cocktail Adv. Mater. 24, 6479-6483 10.1002/adma.201202687
3. Butters, D. J., Ghersi, D., Wilcken, N., Kirk, S. J., and Mallon, P. T. (2010) Addition of drug/s to a chemotherapy regimen for metastatic breast cancer Cochrane Database Syst. Rev. 11, CD003368 10.1002/14651858.CD003368.pub3
4. Coquet, I., Pavie, J., Palmer, P., Barbier, F., Legriel, S., Mayaux, J., Molina, J. M., Schlemmer, B., and Azoulay, E. (2010) Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era Crit. Care 14, R107 10.1186/cc9056
5. Hu, Q., Sun, W., Wang, C., and Gu, Z. (2016) Recent advances of cocktail chemotherapy by combination drug delivery systems Adv. Drug Delivery Rev. 98, 19-34 10.1016/j.addr.2015.10.022
6. Calabrò, F., Lorusso, V., Rosati, G., Manzione, L., Frassineti, L., Sava, T., Di Paula, E. D., Alonso, S., and Sternberg, C. N. (2009) Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma Cancer 115, 2652-2659 10.1002/cncr.24313
7. Lehár, J., Krueger, A. S., Avery, W., Heilbut, A. M., Johansen, L. M., Price, E. R., Rickles, R. J., Short, G. F., III, Staunton, J. E., Jin, X., Lee, M. S., Zimmermann, G. R., and Borisy, A. A. (2009) Synergistic drug combinations tend to improve therapeutically relevant selectivity Nat. Biotechnol. 27, 659-666 10.1038/nbt.1549
8. Allen, T. M. and Cullis, P. R. (2013) Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Delivery Rev. 65, 36-48 10.1016/j.addr.2012.09.037
9. Ding, X., Cai, K., Luo, Z., Li, J., Hu, Y., and Shen, X. (2012) Biocompatible magnetic liposomes for temperature triggered drug delivery Nanoscale 4, 6289-6292 10.1039/c2nr31292a
10. Xiao, H., Song, H., Yang, Q., Cai, H., Qi, R., Yan, L., Liu, S., Zheng, Y., Huang, Y., Liu, T., and Jing, X. (2012) A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance Biomaterials 33, 6507-6519 10.1016/j.biomaterials.2012.05.049
11. Song, H., Xiao, H., Zheng, M., Qi, R., Yan, L., and Jing, X. (2014) A biodegradable polymer platform for co-delivery of clinically relevant oxaliplatin and gemcitabine J. Mater. Chem. B 2, 6560-6570 10.1039/C4TB00678J
12. Li, M., Tang, Z., Lv, S., Song, W., Hong, H., Jing, X., Zhang, Y., and Chen, X. (2014) Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin Biomaterials 35, 3851-3864 10.1016/j.biomaterials.2014.01.018
13. Miao, L., Guo, S., Zhang, J., Kim, W. Y., and Huang, L. (2014) Nanoparticles with precise ratiometric co-Loading and co-Delivery of gemcitabine monophosphate and cisplatin for treatment of bladder cancer Adv. Funct. Mater. 24, 6601-6611 10.1002/adfm.201401076
14. Pathak, R. K. and Dhar, S. (2015) A nanoparticle cocktail: temporal release of predefined drug combinations J. Am. Chem. Soc. 137, 8324-8327 10.1021/jacs.5b03078
15. Cai, L., Xu, G., Shi, C., Guo, D., Wang, X., and Luo, J. (2015) Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: a synergistic combination nanotherapy for ovarian cancer treatment Biomaterials 37, 456-468 10.1016/j.biomaterials.2014.10.044
16. Fang, Y., Zheng, G., Yang, J., Tang, H., Zhang, Y., Kong, B., Lv, Y., Xu, C., Asiri, A. M., Zi, J., Zhang, F., and Zhao, D. (2014) Dual-pore mesoporous carbon@silica composite core-shell nanospheres for multidrug delivery Angew. Chem., Int. Ed. 53, 5366-5370 10.1002/anie.201402002
17. Zhou, S., Sha, H., Ke, X., Liu, B., Wang, X., and Du, X. (2015) Combination drug release of smart cyclodextrin-gated mesoporous silica nanovehicles Chem. Commun. 51, 7203-7206 10.1039/C5CC00585J
18. Meng, H., Wang, M., Liu, H., Liu, X., Situ, A., Wu, B., Ji, Z., Chang, C. H., and Nel, A. E. (2015) Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice ACS Nano 9, 3540-3557 10.1021/acsnano.5b00510
19. Sengupta, S., Eavarone, D., Capila, I., Zhao, G., Watson, N., Kiziltepe, T., and Sasisekharan, R. (2005) Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature 436, 568-572 10.1038/nature03794
20. Ma, L., Kohli, M., and Smith, A. (2013) Nanoparticles for combination drug therapy ACS Nano 7, 9518-9525 10.1021/nn405674m
21. Parhi, P., Mohanty, C., and Sahoo, S. K. (2012) Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy Drug Discovery Today 17, 1044-1052 10.1016/j.drudis.2012.05.010
22. Lammers, T., Subr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., and Storm, G. (2009) Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers Biomaterials 30, 3466-3475 10.1016/j.biomaterials.2009.02.040
23. Bae, Y., Diezi, T. A., Zhao, A., and Kwon, G. S. (2007) Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents J. Controlled Release 122, 324-330 10.1016/j.jconrel.2007.05.038
24. Liu, J., Liu, W., Weitzhandler, I., Bhattacharyya, J., Li, X., Wang, J., Qi, Y., Bhattacharjee, S., and Chilkoti, A. (2015) Ring-opening polymerization of prodrugs: a versatile approach to prepare well-defined drug-loaded nanoparticles Angew. Chem., Int. Ed. 54, 1002-1006 10.1002/anie.201409293
25. Greco, F. and Vicent, M. J. (2009) Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines Adv. Drug Delivery Rev. 61, 1203-1213 10.1016/j.addr.2009.05.006
26. Liao, L., Liu, J., Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Hammond, P. T., and Johnson, J. A. (2014) A convergent synthetic platform for single-nanoparticle combination cancer therapy: ratiometric loading and controlled release of cisplatin, doxorubicin, and camptothecin J. Am. Chem. Soc. 136, 5896-5899 10.1021/ja502011g
27. Aryal, S., Hu, C. M. J., and Zhang, L. (2011) Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy Mol. Pharmaceutics 8, 1401-1407 10.1021/mp200243k
28. Huang, P., Wang, D., Su, Y., Huang, W., Zhou, Y., Cui, D., Zhu, X., and Yan, D. (2014) Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy J. Am. Chem. Soc. 136, 11748-11756 10.1021/ja505212y
29. Bazzanini, R., Gouy, M., Peyrottes, S., Gosselin, G., Périgaud, C., and Manfredini, S. (2005) Synthetic approaches to a mononucleotide prodrug of cytarabine Nucleosides, Nucleotides Nucleic Acids 24, 1635-1649 10.1080/15257770500267006
30. Sk, U. H., Kambhampati, S. P., Mishra, M. K., Lesniak, W. G., Zhang, F., and Kannan, R. M. (2013) Enhancing the efficacy of Ara-C through conjugation with PAMAM dendrimer and linear PEG: a comparative study Biomacromolecules 14, 801-810 10.1021/bm3018615
31. Mai, Y., Zhou, Y., and Yan, D. (2005) Synthesis and size-controllable self-assembly of a novel amphiphilic hyperbranched multiarm copolyether Macromolecules 38, 8679-8686 10.1021/ma051377y
32. Kwon, G., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y., and Kataoka, K. (1993) Micelles based on AB block copolymers of poly(ethylene oxide) and poly(β-benzyl L-aspartate) Langmuir 9, 945-949 10.1021/la00028a012
33. Yang, Z., Lee, J. H., Jeon, H. M., Han, J. H., Park, N., He, Y., Lee, H., Hong, K. S., Kang, C., and Kim, J. S. (2013) Folate-based near-infrared fluorescent theranostic gemcitabine delivery J. Am. Chem. Soc. 135, 11657-11662 10.1021/ja405372k
34. Deshmukh, M., Chao, P., Kutscher, H. L., Gao, D., and Sinko, P. J. (2010) A series of alpha-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicity J. Med. Chem. 53, 1038-1047 10.1021/jm901029n
35. Goff, R. D. and Thorson, J. S. (2010) Assessment of chemoselective neoglycosylation methods using chlorambucil as a model J. Med. Chem. 53, 8129-8139 10.1021/jm101024j
36. Mayer, L. D., Harasym, T. O., Tardi, P. G., Harasym, N. L., Shew, C. R., Johnstone, S. A., Ramsay, E. C., Bally, M. B., and Janoff, A. S. (2006) Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice Mol. Cancer Ther. 5, 1854-1863 10.1158/1535-7163.MCT-06-0118
37. Tardi, P. G., Gallagher, R. C., Johnstone, S., Harasym, N., Webb, M., Bally, M. B., and Mayer, L. D. (2007) Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo Biochim. Biophys. Acta, Biomembr. 1768, 678-687 10.1016/j.bbamem.2006.11.014
38. Chou, T. C. (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method Cancer Res. 70, 440-446 10.1158/0008-5472.CAN-09-1947
39. Lee, S.-M., O'Halloran, T. V., and Nguyen, S. T. (2010) Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy J. Am. Chem. Soc. 132, 17130-17138 10.1021/ja107333g
40. Huang, P., Hu, M., Zhou, L., Wang, Y., Pang, Y., Tong, G., Huang, W., Su, Y., and Zhu, X. (2015) Self-delivery nanoparticles from an amphiphilic covalent drug couple of irinotecan and bendamustine for cancer combination chemotherapy RSC Adv. 5, 86254-86264 10.1039/C5RA16511C
41. Hu, M., Huang, P., Wang, Y., Su, Y., Zhou, L., Zhu, X., and Yan, D. (2015) Synergistic combination chemotherapy of camptothecin and floxuridine through self-Assembly of amphiphilic drug-drug conjugate Bioconjugate Chem. 26, 2497-2506 10.1021/acs.bioconjchem.5b00513